The Dementias and Neurodegeneration (DeNDRoN) Specialty is one of over 30 Specialties which bring together communities of clinical practice to provide national networks of research expertise. Our membership is made up of research-interested clinicians and practitioners at both national and local levels.
The NIHR is the most integrated health research system in the world, and the largest national clinical research funder in Europe. The NIHR Clinical Research Network (CRN) supported more than 100 new Dementias and Neurodegeneration (DeNDRoN) studies last year, and recruited 29430 patients to Dementias and Neurodegeneration trials.
The NIHR supports research studies through our funding programmes, training and support for health researchers, and through providing world-class research facilities. We also support dialogue between the life sciences industry and charities to benefit all, and facilitate the involvement of patients and the public to make research more effective.
The Government’s Challenge on Dementia sets out the ambition for England to be the best place in the world to undertake research into dementia and other neurodegenerative diseases by 2020. UK Dementia research is fully embedded in NHS clinical practice. Expertise exists in all stages and types of dementia, from pre-symptomatic through mild cognitive impairment to more advance stages. This includes Alzheimer’s disease, Lewy body dementias, vascular cognitive impairment, mixed dementias, frontotemporal dementia and other less common forms. Studies span the full translational research pathway.